NCT06398847 Virtual Reality (VR) Self-Hypnosis Software
| NCT ID | NCT06398847 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Icahn School of Medicine at Mount Sinai |
| Condition | Musculoskeletal Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 25 participants |
| Start Date | 2026-03-26 |
| Primary Completion | 2026-06-30 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
This single-site study of self-hypnosis software using an off-the-shelf virtual reality (VR) device (OculusGo™) to determine the software's safety, usability, and preliminary efficacy in pain relief for HIV-associated chronic pain patients. This is funded under the i Prism Funding through Mount Sinai Innovations.
Eligibility Criteria
Patient Eligibility Inclusion Criteria: * Adults age ≥18 * Confirmed diagnosis of HIV, currently on a stable antiretroviral regimen ≥ 90 days. * Documentation of chronic pain associated with HIV for≥90 days * Stable pain management regimen ≥90 days, or no pain treatments ≥90 days * Average pain intensity of 3 or greater on the NRS of the mean daily scores reported between Visit 1 and Visit 2 * Access to the internet via smartphone, computer, or tablet 7. Fluent in English * Capable of giving informed consent and willingness to comply with study procedures. Exclusion Criteria: * A co-occurring medical or psychiatric condition which would make participation in the study or complicate measurement of changes associated with the intervention. * Concurrent participation in another investigational protocol for pain treatment * A psychiatric disorder, medical condition, or other life circumstance, which in the opinion of the PI, would contraindicate attendance at sessions, or make it unlikely